Qualcomm wins fight against $1 billion EU antitrust fine

Qualcomm wins fight against  billion EU antitrust fine


Qualcomm Inc. President and CEO Cristiano Amon speaks during the company’s press event for CES 2022 at the Mandalay Bay Convention Center on January 4, 2022 in Las Vegas, Nevada. CES, the world’s largest annual consumer technology trade show, is being held in person from January 5-7, with some companies deciding to participate virtually only or canceling their attendance due to concerns over the major surge in COVID-19 cases.

Ethan Miller | Getty Images

U.S. chipmaker Qualcomm on Wednesday won its fight against a 997 million euro ($1.05 billion) fine imposed by EU antitrust regulators four years ago, dealing a major setback to EU antitrust chief Margrethe Vestager’s crackdown on Big Tech.

The European Commission in its 2018 decision said Qualcomm paid billions of dollars to Apple from 2011 to 2016 to use only its chips in all its iPhones and iPads in order to block out rivals such as Intel Corp.

Qualcomm’s fine is one of several imposed by Vestager on companies ranging from Alphabet unit Google to banks and truckmakers over anti-competitive practices. Apple, Amazon and Facebook are being investigated.

The General Court, Europe’s second-highest, annulled the EU finding and faulted the EU competition enforcer over the handling of the case.

“A number of procedural irregularities affected Qualcomm’s rights of defence and invalidate the Commission’s analysis of the conduct alleged against Qualcomm,” judges said.

“The Commission did not provide an analysis which makes it possible to support the findings that the payments concerned had actually reduced Apple’s incentives to switch to Qualcomm’s competitors in order to obtain supplies of LTE chipsets for certain iPad models to be launched in 2014 and 2015,” they said.

The EU competition enforcer can appeal on matters of law to the EU Court of Justice (CJEU), Europe’s highest court.

The Commission said it would carefully study the judgement and its implications and consider its next steps. Qualcomm did not immediately respond to an emailed request for comment.

“The high-level conclusion is that the Court is telling the Commission to be extremely cautious in pricing abuses,” said Assimakis Komninos, a partner at law firm White & Case.

“The Commission will now be very hesitant to start investigations into such cases unless they are really sure,” he said.

This is the second major defeat for Vestager who in January lost the court’s backing for a 1.06 billion euro fine on Intel 12 years ago for squeezing rival Advanced Micro Devices.

Vestager’s next test is on Sept. 14 when the General Court will rule on Google’s challenge against a record 4.34 billion euro antitrust fine levied for using its Android mobile operating system to squeeze out rivals.

The case is T-235/18.



Source

Several killed after fire in Swiss ski resort bar
World

Several killed after fire in Swiss ski resort bar

Police officers walk at the site of an explosion that ripped through a bar in Crans-Montana on January 1, 2026. Several people were killed and others injured when an explosion ripped through a bar in the luxury Alpine ski resort town of Crans Montana, Swiss police said early on January 1. Maxime Schmid | Afp […]

Read More
U.S. grants TSMC annual licence to import U.S. chipmaking tools into China
World

U.S. grants TSMC annual licence to import U.S. chipmaking tools into China

TSMC offices in San Jose, California, on April 18, 2024. Bloomberg | Bloomberg | Getty Images The U.S. government has granted an annual licence to Taiwan Semiconductor Manufacturing to import U.S. chip manufacturing equipment to its facilities in Nanjing, China, the chipmaker said on Thursday. The approval “ensures uninterrupted fab operations and product deliveries,” the […]

Read More
Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market
World

Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market

Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) Ucg | Universal Images Group | Getty Images Novo Nordisk’s shift from a market darling to a serious underperformer has set the stage for a transitional 2026 as the Danish drugmaker […]

Read More